Expanding the Targets Available to Therapeutic Antibodies via Novel Disease-specific Markers

TCR Mimic Monoclonal Antibodies Induce Apoptosis of Tumor Cells via Immune Effector-Independent Mechanisms

(2011) B. Verma et al.   JOURNAL OF IMMUNOLOGY

An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer

(2011) O. Hawkins et al.   JOURNAL OF IMMUNOLOGY

Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines

(2011) Estrella Carballido et al.   Current Oncology Reports

A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody

(2010) Raktima Bhattacharya et al.   JOURNAL OF CELLULAR PHYSIOLOGY

TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models

(2010) Bhavna Verma et al.   JOURNAL OF IMMUNOLOGY

Single-Chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity against Lethal West Nile Virus Infection

(2010) S. Kim et al.   JOURNAL OF IMMUNOLOGY

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties

(2009) Bhavna Verma et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

(2009) M. I. Vega et al.   CLINICAL CANCER RESEARCH

Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201

(2008) Oriana E. Hawkins et al.   JOURNAL OF PROTEOME RESEARCH